See Our Winners, Runners Up & Shortlisted

The 2025 winners and runners-up were announced during a special ceremony taking place at the 16th World ADC San Diego.

Best ADC Platform Technology

Winner:

DXd ADC Technology
Daiichi Sankyo

Runner Up:

ConjuALLTM
LigaChem Biosciences

Shortlisted:

  • AbClick – AbTis
  • AJICAP – Ajinomoto Bio-Pharma Services
  • ConjuAll – LigaChem Biosciences
  • Conjugation Toolbox - AsymBio
  • GlycoConnect – Synaffix, a Lonza Company
  • SMARTag – Catalent
Best New ADC Drug Developer

Winner:

CrossBridge Bio

Runner Up:

Aarvik Therapeutics

Shortlisted:

  • Adcentrx Therapeutics
  • Adcytherix
  • OnCusp Therapeutics
  • T-E Meds
Most Promising ADC to Watch

Winner:

IKS014
Iksuda Therapeutics & Fosun Pharma

Runner Up:

Emiltatug ledadotin
Mersana Therapeutics

Shortlisted:

  • CS5001 - CStone Pharma
  • Emiltatug ledadotin- Mersana Therapeutics
  • Fetrastobart vedotin - Pfizer
  • MYTX-011 - Mythic Therapeutics
  • PYX-201 - Pyxis Oncology
Best ADC Clinical Impact

Winner:

DATROWAY
AstraZeneca & Daiichi Sankyo

Runner Up:

EMRELIS
AbbVie

Shortlisted:

  • BL-B01D1 – BMS & SystImmune
  • EMRELIS - AbbVie
  • HER3-DXd - Daiichi Sankyo & Merck & Co.
  • PADCEV (Keytruda bladder cancer combination) - Astellas & Pfizer
  • Rina-S - GenMab
Best CDMO

Winner:

WuXi XDC

Runner Up:

Lonza

  • Abzena
  • BSP Pharmaceuticals
  • Cohance Lifesciences
  • Lonza
  • MilliporeSigma
  • Piramal Pharma Solutions
Best CRO

Winner:

WuXi XDC

Runner Up:

NJ Bio, Inc.

  • Charles River Laboratories
  • ChemExpress
  • Crown Bioscience
  • HUB Organoids
  • ICON Plc
  • NJ Bio, Inc.
  • Precision For Medicine
  • Sterling Pharma Solutions
Best Clinical Publication 2024

Winner:

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

 

Best Preclinical Publication 2024

Winner:

Exo-Cleavable Linkers: Enhanced Stability and Therapeutic Efficacy in Antibody-Drug Conjugates

Best Poster 2025

Winner:

First-in-class click chemistry-based pre-targeting of CEACAM5 selectively activates an MMAE payload at tumors – Shasqi

Outstanding Academic Investigator Award

Winner:

Professor David Spring
University of Cambridge

The George R. Pettit Individual Input to the Field 2024

Winner:

Raffaele Colombo, Zymeworks

The Toshinori Agatsuma Long Standing Contribution to the Field Award

Winner:

Paul Polakis

Screenshot-2026-04-29-170158-768x507
Explore World ADC San Diego's Agenda

Discover the latest industry breakthroughs and insights to be shared at the biggest ADC event, ahead of the awards' gala.

Screenshot-2026-04-29-170322-768x494
Partner With Us

Position yourself in front of the pioneers trailblazing ADCs to standard of care treatments.

World ADC Awards 2025
View the 2025 Shortlisted

Have a look at the shortlisted candidates to be recognized this year because of their exceptional work propelling the ADC field to new heights.